Author: Brittney Wheeler

An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine and other sites.

Researchers at Washington University School of Medicine in St. Louis and Georgia Tech are leading a study using computer algorithms to identify stressors on social media linked to the COVID-19 pandemic.

The School of Medicine’s Jennifer A. Philips, MD, PhD, has set up a screening platform to test compounds for activity against the COVID-19 virus. Her lab has screened dozens of compounds and is prepared to accept more suggestions of promising candidate molecules.

For 38 years, Ida Early has contributed to many facets of Washington University. She reflects on the moments that have led her to this point as she prepares for retirement.

The crowdsourced supercomputing project Folding@home, based at the School of Medicine, shifted focus months ago to coronavirus research. Now, units at Washington University and elsewhere, individuals and companies have joined the effort.

An interruption in blood flow to the brain causes a stroke. A new study from Washington University School of Medicine in St. Louis reveals that stroke care in rural areas lags significantly behind that available in urban centers.

Faculty at the Washington University School of Medicine have joined an international effort led by the Foundation for Innovative New Diagnostics and the World Health Organization (WHO) to evaluate COVID-19 antibody tests for use as diagnostics in places with limited resources.

A neuroscientist’s arm cast led him and fellow School of Medicine researchers to find previously undetected neuronal pulses in the human brain that activate after an immobilizing illness or injury. The pulses appeared on MRI scans used to measure brain activity.

Researchers at Washington University School of Medicine report that specific types of retinal cells that carry the vast majority of visual signals from the human retina to the brain efficiently process and compress that information so it can be transferred. The study may advance our understanding of eye diseases involving the retina.

Scientists at the Washington University School of Medicine have developed a mouse model of COVID-19 that is expected to speed up the search for drugs and vaccines for the potentially deadly disease.